Results of late-breaking developments from the POSEIDON Phase III trial revealed improved overall survival with a limited course of five cycles of tremelimumab added to durvalumab plus platinum chemotherapy.
Friday
September
29
Top Stories
Sponsored
Initiation of Venetoclax for Adult Patients with Chronic Lymphocytic Leukemia (CLL)
This video will offer guidance on initiation protocols for venetoclax treatment in adult patients with chronic lymphocytic leukemia (CLL).
Association of Geriatric Measures and Global Frailty With Cognitive Decline After Allogeneic Hematopoietic Cell Transplantation in Older Adults
In this study, researchers determined that baseline geriatric measures and frailty and frailty were not associated with significant cognitive change among adult
Development and Validation of a Novel TNM Staging N-Classification of Oral Cavity Squamous Cell Carcinoma
Among patients with resected oral cavity squamous cell carcinoma, a new N-classification improved staging performance when compared against TNM-8-N.
Utilizing Biomarkers to Optimize Treatment for Upper Gastrointestinal Cancers
At the Great Debates & Updates in Gastrointestinal Malignancies meeting, Nataliya Uboha, MD, PhD, University of Wisconsin, Carbone Cancer Center, Madison, Wi
Trending
Lung Cancer
Start your day with an email
that tells you what’s happening
and why it matters.
<!-- BEGIN ADVERTSERVE CODE -->
<div id="mobile_block_ad_1"><script type="text/javascript">
var _avp = _avp || [];
_avp.push({ tagid: 'mobile_block_ad_1', alias: '/', type: 'banner', zid: 1669, pid: 0, onscroll: 0, inview: true, secure: true });
</script></div>
<!-- END ADVERTSERVE CODE -->